Further studies and exploration of novel serum markers are warranted to enhance our understanding and clinical management of this disease.15 Currently, the primary serum markers used in clinical practice for diagnosing and monitoring HCC are DCP and AFP-L3. Here, AFP is linked to hepatocellular carcinoma.